Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
Heterologous vaccine regimens have gained substantial interest as a way to mitigate intermittent supply shortages and to ameliorate the immunogenicity and safety of COVID-19...






